. 2014 Jan 15;9(1):e81542. doi: 10.1371/journal.pone.0081542

Table 4. Inhibition effects (IC₅₀) of different ligands in replacement assay of the 1, 8-ANS-bound SlSCPx-2.

Ligands	IC₅₀ (µM)	RBA(%)	Ligands	IC₅₀ (µM)	RBA (%)
Arachidonate	18.12±0.83	277	Linoleic acid	143.00±0.99	35
Oleic acid	24.37±1.14	206	AeSCPI-1	160.90±5.03	31
Stearic acid	39.82±1.17	126	Ergosterol	167.60±0.34	30
Cholesterol	50.13±0.80	100	Stigmasterol	189.60±2.29	26
AeSCPI-2	55.03±0.66	91	Octanoate	217.90±1.53	23
Palmitic acid	59.05±1.29	85

IC₅₀: the concentration at 50% inhibition and the data are derived from assays described in Fig. 4B. RBA: relative binding affinity. It was calculated by dividing the IC₅₀ of cholesterol ( = 100%) by the IC₅₀ of each chemical.

Table 4. Inhibition effects (IC50) of different ligands in replacement assay of the 1, 8-ANS-bound SlSCPx-2.

Table 4. Inhibition effects (IC₅₀) of different ligands in replacement assay of the 1, 8-ANS-bound SlSCPx-2.